SangStat and Abgenix in antibody collaboration

SANG acquired an exclusive worldwide license to market and sell ABX-CBL, a mouse monoclonal antibody against CBL antigen ( CD147) developed by ABGX, and the right to commercialize other anti-CD147 ant...